Five putative drug resistance parameters (MDR1/P‐glycoprotein, MDR‐associated protein, glutathione‐S‐transferase, bcl‐2 and topoisomerase IIα) in 57 newly diagnosed acute myeloid leukaemias
- 1 October 1997
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 59 (4), 206-215
- https://doi.org/10.1111/j.1600-0609.1997.tb00979.x
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- MDR1/P-glycoprotein in haematological neoplasmsEuropean Journal Of Cancer, 1996
- Molecular Epidemiology: Carcinogens, DNA Adducts, and Cancer -- Still a Long Way to GoJNCI Journal of the National Cancer Institute, 1995
- Multidrug resistance gene (mdr1) RNA levels in relation to P-glycoprotein content of leukemic cells from patients with acute leukemiaMedical Oncology, 1995
- Discovering the Truth About Tamoxifen: Problems of Multiplicity in Statistical Evaluation of Biomedical DataJNCI Journal of the National Cancer Institute, 1995
- Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implicationsThe Lancet, 1994
- Cytogenetics and oncogenes in leukemiaCurrent Opinion in Oncology, 1994
- Expression of Resistance Genes in Acute LeukemiaLeukemia & Lymphoma, 1994
- Cytostatic drug resistance: parallel assessment of glutathione‐based detoxifying enzymes, O6‐alkylguanine‐DNA‐alkyltransferase and P‐glycoprotein in adult patients with leukaemiaBritish Journal of Haematology, 1993
- Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocationCell, 1986
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979